iNtRON Biotechnology, Inc.
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
048530 | KO
Overview
Corporate Details
- ISIN(s):
- KR7048530000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 701~704호, 성남시
- Website:
- https://intronbio.com:6001
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
iNtRON Biotechnology, Inc. is a biopharmaceutical company specializing in the development of novel drugs and molecular diagnostics. The company is a recognized leader in bacteriophage and endolysin-based technologies, focusing on creating innovative therapeutics to combat infectious diseases, including antibiotic-resistant super-bacteria. Its core activities encompass the development of 'first-in-class' biopharmaceutical pipelines, such as its PHAGERIA® platform, which targets the gut microbiome. In addition to therapeutics, iNtRON develops and manufactures molecular diagnostic assays and reagents for human and animal diseases, utilizing technologies like real-time PCR. The company aims to be a global R&D leader in the immune and immunotherapeutics market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 91.8 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-06-12 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 28.3 KB | ||
| 2025-06-12 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 20.1 KB | ||
| 2025-05-19 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 96.1 KB | ||
| 2025-04-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 96.1 KB | ||
| 2025-04-09 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 28.0 KB | ||
| 2025-04-09 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 28.0 KB | ||
| 2025-04-09 00:00 |
Regulatory News Service
신탁계약해지결과보고서
|
Korean | 20.1 KB | ||
| 2025-04-09 00:00 |
Transaction in Own Shares
신탁계약해지결과보고서
|
Korean | 20.8 KB | ||
| 2025-04-03 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 97.7 KB | ||
| 2025-03-19 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 21.6 KB | ||
| 2025-03-13 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 99.2 KB |
Automate Your Workflow. Get a real-time feed of all iNtRON Biotechnology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for iNtRON Biotechnology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for iNtRON Biotechnology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
